XJet is a
provider of groundbreaking metal and ceramic additive manufacturing
technologies and solutions. Founded in 2005, XJet has developed and introduced
the revolutionary NanoParticle Jetting™ technology. With a decade of research
behind it, our NPJ technology enables the production of metal or ceramic parts
with the same ease and versatility of inkjet printing without compromising
throughput or quality. Our world-class team of skilled industry veterans and
dynamic R&D specialists holds over 75 registered and pending patents.
Leveraging our proprietary technology and proven expertise, XJet is redefining
the metal and ceramic AM industries.
Materialise Medical, which
has pioneered many of the leading medical applications of 3D printing, enables
researchers, engineers and clinicians to revolutionize innovative
patient-specific treatment that helps improve and save lives. Materialise
Medical’s open and flexible platform of software and services, Materialise
Mimics, forms the foundation of certified Medical 3D Printing, in clinical as
well as research environments, offering virtual planning software tools,
3D-printed anatomical models, and patient-specific surgical guides and
implants. For additional information, please visit: http://www.materialise.com/en/medical.
CELLINK is one of the leading 3D Bioprinting companies in the world and the first company to commercialize a universal bioink for 3D Bioprinting of human tissues and organs. CELLINK manufactures state of the art, cost effective 3D Bioprinters that are used by world renowned research institutions in over 50 countries and 400+ labs. Leading industry players such as Harvard, MIT, Johnson & Johnson, Merck and Toyota are working with CELLINK to shape the future through bioprinting.